AI Health Technology Limited (HKG:1715)
Hong Kong · Delayed Price · Currency is HKD 0.4650
-0.0100 (-2.11%)
At close: Jun 1, 2026
AI Health Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -35.56 | -35.85 | -49.32 | -43.21 | -44.35 |
Depreciation & Amortization | 2.58 | 4.12 | 5.39 | 6.94 | 6.53 |
Other Amortization | 0.07 | 0.12 | 0.13 | 0.26 | 0.28 |
Loss (Gain) From Sale of Assets | - | - | 0.06 | 0.13 | 0.01 |
Asset Writedown & Restructuring Costs | 0.02 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | -0.54 | -0.26 | -2.96 | - |
Loss (Gain) on Equity Investments | 1.03 | 0.34 | 0.57 | 0.39 | 0.74 |
Provision & Write-off of Bad Debts | -1.6 | 4.02 | 5.72 | 2.06 | 0.13 |
Other Operating Activities | 8.73 | 7.78 | 13.04 | 4.33 | 2.68 |
Change in Accounts Receivable | 20.31 | -10.26 | -9.97 | 14.56 | 20.88 |
Change in Inventory | 7.01 | 15.74 | 30.86 | -18.37 | 1.99 |
Change in Accounts Payable | -1.87 | 4.4 | -5.82 | 1.92 | 0.12 |
Change in Unearned Revenue | 4.67 | 0.1 | -1.42 | -0.65 | -1.23 |
Change in Other Net Operating Assets | -15.48 | -25.18 | 25.65 | -41.35 | 1.21 |
Operating Cash Flow | -10.09 | -35.21 | 14.62 | -75.93 | -11.02 |
Capital Expenditures | - | -0.16 | -0.62 | -0.77 | -2.22 |
Sale of Property, Plant & Equipment | - | 0.05 | 0.01 | 0.07 | 0 |
Divestitures | - | - | 0.4 | - | - |
Investment in Securities | - | - | - | 15.66 | 5.04 |
Other Investing Activities | 0.42 | 0.01 | 0.01 | 0.06 | 3.85 |
Investing Cash Flow | 0.42 | -0.1 | -0.2 | 15.03 | 6.68 |
Long-Term Debt Issued | 33.56 | 35.57 | 51.15 | 73.6 | 23 |
Total Debt Issued | 33.56 | 35.57 | 51.15 | 73.6 | 23 |
Long-Term Debt Repaid | -47.45 | -46.48 | -63.74 | -26.59 | -29.69 |
Total Debt Repaid | -47.45 | -46.48 | -63.74 | -26.59 | -29.69 |
Net Debt Issued (Repaid) | -13.89 | -10.91 | -12.59 | 47.01 | -6.69 |
Issuance of Common Stock | 51.54 | 20.22 | 27.6 | - | - |
Other Financing Activities | -3.14 | -5.68 | -6.88 | -7.71 | -4.05 |
Financing Cash Flow | 34.51 | 3.63 | 8.13 | 39.3 | -10.74 |
Foreign Exchange Rate Adjustments | -0.07 | 0.03 | 0.04 | 0.62 | -0.75 |
Net Cash Flow | 24.78 | -31.65 | 22.6 | -20.99 | -15.84 |
Free Cash Flow | -10.09 | -35.37 | 14 | -76.7 | -13.24 |
Free Cash Flow Margin | -21.29% | -38.50% | 16.59% | -86.97% | -9.20% |
Free Cash Flow Per Share | -0.04 | -0.05 | 0.21 | -1.28 | -0.22 |
Cash Interest Paid | 3.14 | 4.16 | 7.05 | 5.73 | 1.51 |
Cash Income Tax Paid | - | - | 0.05 | 0 | 0.08 |
Levered Free Cash Flow | 4.79 | -34.41 | 31.34 | -59.1 | 3.65 |
Unlevered Free Cash Flow | 6.75 | -31.8 | 36.16 | -55.93 | 4.59 |
Change in Working Capital | 14.64 | -15.21 | 39.29 | -43.88 | 22.97 |